Catalyst Wire Dossier Catalyst Wire Dossier

Legalon SIL

silibinin · Rottapharm
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Legalon SIL, covering 2012-02-17 to 2015-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C [Phase 2, Phase 3]

See pricing